Related Experiment Video

Updated: Aug 13, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Analysis of antihypertensive treatment outcome and stroke

J J McNeil1

  • 1Department of Social and Preventive Medicine Monash Medical School Alfred Hospital Prahran Victoria, Australia.

Clinical and Experimental Hypertension. Part A, Theory and Practice
|January 1, 1989
PubMed

Insights

Hypertension is a primary risk factor for stroke. Antihypertensive drug studies show significant reductions in fatal and non-fatal stroke events, suggesting blood pressure control is key to preventing cerebrovascular disease.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Hypertension is the leading risk factor for cerebrovascular disease, including both thromboembolic and hemorrhagic stroke.
  • The risk of stroke associated with hypertension increases with age and higher blood pressure levels.

Purpose of the Study:

  • To review the impact of antihypertensive therapy on stroke incidence and mortality.
  • To evaluate the effectiveness of blood pressure reduction interventions in preventing stroke.

Main Methods:

  • Analysis of major intervention studies using antihypertensive drugs.
  • Review of placebo-controlled trials assessing the effect of blood pressure reduction on stroke outcomes.
  • Examination of epidemiological data, including evidence from the Mayo Clinic, on stroke trends.

Main Results:

  • Antihypertensive therapy consistently demonstrates a decline in fatal and non-fatal stroke in treated groups.
  • Placebo-controlled studies showed a mean reduction of 47% in fatal stroke and 51% in non-fatal stroke with a 6 mmHg blood pressure difference.
  • Evidence suggests a substantial decline in stroke incidence and mortality correlating with the introduction of antihypertensive therapy.

Conclusions:

  • Antihypertensive therapy is a critical intervention for reducing stroke burden.
  • Widespread blood pressure reduction campaigns are likely responsible for observed declines in stroke incidence and mortality.
  • Effective management of hypertension is paramount in cerebrovascular disease prevention efforts.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...